The Company is a provider of innovative medical devices used in minimally invasive, image-guided procedures to treat peripheral vascular disease and local oncology therapy options for treating cancer.


Updates from The Motley Fool

Latest updates on AngioDynamics from Fool.com.


Stock Performance

ANGO vs. S&P 500 | 2 Year Performance
View Interactive ANGO Charts
Sponsored by

Key Data Points

Primary metrics and data points about AngioDynamics.
Current Price: $17.01
Prev Close: $17.02
Open: $17.01
Bid: $16.96
Ask: $17.08
Day's Range: $16.79 - $17.15
52wk Range: $9.71 - $17.54
Volume: 177,933
Avg Vol 149,921
Market Cap: $617.13M
P/E (ttm): -14.07
EPS (ttm): -$1.21
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about AngioDynamics.
CAPS Rating 3 out of 5
 
114 Outperform
15 Underperform
CAPS All Stars
 
32 Outperform
5 Underperform

How do you think AngioDynamics will perform against the market?



You pick for AngioDynamics is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Joseph DeVivo, CEO

29% Approve

Based on 17 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for AngioDynamics.

The Company is a provider of innovative medical devices used in minimally invasive, image-guided procedures to treat peripheral vascular disease and local oncology therapy options for treating cancer.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Healthcare IT